Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Co. stock logo
CVS
CVS Health
$67.27
-0.1%
$74.61
$64.41
$83.25
$84.79B0.5210.61 million shs2.52 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.44
-0.3%
$155.47
$143.13
$175.97
$352.89B0.537.32 million shs1.95 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Co. stock logo
CVS
CVS Health
-0.65%-2.98%-15.13%-7.79%-6.84%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.15%+0.74%-5.75%-7.96%-9.72%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CVS Health Co. stock logo
CVS
CVS Health
5 of 5 stars
4.45.03.33.93.72.53.8
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9338 of 5 stars
3.23.04.23.93.62.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Co. stock logo
CVS
CVS Health
2.80
Moderate Buy$89.4432.96% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8620.09% Upside

Current Analyst Ratings

Latest JNJ and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/10/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
4/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$83.00 ➝ $76.00
4/4/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
3/15/2024
CVS Health Co. stock logo
CVS
CVS Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$93.00 ➝ $94.00
3/13/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
3/6/2024
CVS Health Co. stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$78.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Co. stock logo
CVS
CVS Health
$357.78B0.24$12.06 per share5.58$59.55 per share1.13
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.14$13.47 per share10.87$28.57 per share5.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Co. stock logo
CVS
CVS Health
$8.34B$6.4610.417.410.902.33%15.25%4.55%5/1/2024 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1313.402.4545.26%36.43%15.01%7/18/2024 (Estimated)

Latest JNJ and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
CVS Health Co. stock logo
CVS
CVS Health
$1.69N/A-$1.69N/AN/AN/A  
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/7/202412/31/2023
CVS Health Co. stock logo
CVS
CVS Health
$2.01$2.12+$0.11$2.66$90.58 billion$93.81 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Co. stock logo
CVS
CVS Health
$2.663.95%+6.56%41.18%2 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.25%+5.70%29.68%63 Years

Latest JNJ and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
3/21/2024
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.39%4/19/20244/22/20245/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Co. stock logo
CVS
CVS Health
0.77
0.86
0.63
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Co. stock logo
CVS
CVS Health
80.66%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
CVS Health Co. stock logo
CVS
CVS Health
0.24%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.26 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable

JNJ and CVS Headlines

SourceHeadline
Are You Looking for a High-Growth Dividend Stock?Are You Looking for a High-Growth Dividend Stock?
zacks.com - April 26 at 12:45 PM
5 Stocks in Focus on Their Recent Dividend Hike5 Stocks in Focus on Their Recent Dividend Hike
zacks.com - April 26 at 9:16 AM
Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 26 at 6:13 AM
Johnson & Johnson (NYSE:JNJ)  Shares Down 1.1% Johnson & Johnson (NYSE:JNJ) Shares Down 1.1%
marketbeat.com - April 25 at 6:18 PM
LLY vs. JNJ: Which Big Pharma Stock Is Better?LLY vs. JNJ: Which Big Pharma Stock Is Better?
msn.com - April 25 at 11:47 AM
Johnson & Johnsons (NYSE:JNJ) Dividend Will Be Increased To $1.24Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24
finance.yahoo.com - April 25 at 11:47 AM
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLCJohnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLC
marketbeat.com - April 25 at 5:42 AM
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%
marketbeat.com - April 24 at 4:21 PM
Vanda (VNDA) to Report Q1 Earnings: Whats in the Cards?Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
finance.yahoo.com - April 24 at 3:27 PM
PBIRx Growth Fueled by Johnson & Johnson ERISA LawsuitPBIRx Growth Fueled by Johnson & Johnson ERISA Lawsuit
businesswire.com - April 24 at 2:35 PM
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting WealthThe Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com - April 24 at 7:25 AM
Johnson & Johnson (NYSE:JNJ) Shares Bought by Ninety One UK LtdJohnson & Johnson (NYSE:JNJ) Shares Bought by Ninety One UK Ltd
marketbeat.com - April 24 at 5:44 AM
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold ForeverGot $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
fool.com - April 24 at 5:25 AM
Johnson & Johnson Childrens Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
msn.com - April 24 at 4:42 AM
Johnson and Johnson (JNJ) Elliott Wave technical analysis [Video]Johnson and Johnson (JNJ) Elliott Wave technical analysis [Video]
fxstreet.com - April 24 at 4:42 AM
Warning! These 3 Blue-Chip Stocks Will Have You Seeing RedWarning! These 3 Blue-Chip Stocks Will Have You Seeing Red
investorplace.com - April 23 at 4:30 PM
Johnson & Johnson (NYSE:JNJ) Trading Down 0.1%Johnson & Johnson (NYSE:JNJ) Trading Down 0.1%
marketbeat.com - April 23 at 2:58 PM
4 Stocks to Watch on Their Recent Dividend Hikes4 Stocks to Watch on Their Recent Dividend Hikes
zacks.com - April 23 at 9:46 AM
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Migdal Insurance & Financial Holdings Ltd.Johnson & Johnson (NYSE:JNJ) Shares Purchased by Migdal Insurance & Financial Holdings Ltd.
marketbeat.com - April 23 at 5:27 AM
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)
americanbankingnews.com - April 23 at 1:06 AM
Johnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)Johnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)
marketbeat.com - April 22 at 5:58 PM
Johnson & Johnson to Participate in the Bernsteins 40th Annual Strategic Decisions Conference (SDC)Johnson & Johnson to Participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC)
businesswire.com - April 22 at 4:30 PM
Johnson & Johnson: Legal Woes Are Detrimental But Not FatalJohnson & Johnson: Legal Woes Are Detrimental But Not Fatal
seekingalpha.com - April 22 at 3:55 PM
Johnson & Johnson (NYSE:JNJ) Shares Up 0.8%Johnson & Johnson (NYSE:JNJ) Shares Up 0.8%
marketbeat.com - April 22 at 1:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.